Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of duxap8 in the diagnosis and treatment of hepatocellular carcinoma

A kind of hepatocellular carcinoma, reagent technology, applied in the field of biomedicine

Active Publication Date: 2020-02-18
BEIJING MEDINTELL BIOMED CO LTD +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the research on lncRNA molecules in the regulation mechanism of liver cancer is still in its infancy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of duxap8 in the diagnosis and treatment of hepatocellular carcinoma
  • Application of duxap8 in the diagnosis and treatment of hepatocellular carcinoma
  • Application of duxap8 in the diagnosis and treatment of hepatocellular carcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Example 1 Screening for Gene Markers Related to Hepatocellular Carcinoma

[0087] 1. Sample collection

[0088] The cancer tissues and corresponding paracancerous tissue samples of 50 HBV-infected patients with hepatocellular carcinoma were collected, and 8 cases were randomly selected for high-throughput sequencing. The patients all gave informed consent. agree.

[0089] 2. Preparation of RNA samples

[0090] Tissue RNA was extracted using QIAGEN tissue RNA extraction kit, and the operation was performed according to the specific steps in the manual.

[0091] 3. Quality analysis of RNA samples

[0092] The above extracted RNA was subjected to agarose gel electrophoresis, the concentration and purity of the extracted RNA were detected by Nanodrop2000, the integrity of the RNA was detected by agarose gel electrophoresis, and the RIN value was determined by Agilent2100. The total amount of RNA required for a single library construction is 5ug, the concentration is ≥20...

Embodiment 2

[0103] Example 2 QPCR sequencing to verify the differential expression of DUXAP8 gene

[0104] 1. Using the previously collected cancer tissue samples and para-cancer tissue samples from 50 patients, the differential expression of DUXAP8 gene was verified by large sample QPCR.

[0105] 2. The RNA extraction steps are the same as in Example 1.

[0106] 3. Reverse transcription:

[0107] 1) Mix 1 μg of total RNA template with 2 μl 10× buffer, 2 μl dATP (10 mM), 0.5 μl polyA polymerase, 0.5 μl ribonuclease (RNase) inhibitor and ribonuclease-free water (RNase free water), volume The last is 20 μl, and incubated at 37°C for 1h.

[0108] 2) Add 1 μl of 0.5 μg / μl Oligo(dT) specific RT primer to the reaction tube, and incubate at 70° C. for 5 minutes.

[0109] 3) Immediately incubate on ice for at least 2 minutes to break the secondary structure of RNA and primers.

[0110] 4) Mix the above 20 μl reaction mixture with 4 μl 5× buffer, 1 μl dNTP (10 mM), 0.5 μl M-MLV reverse transcr...

Embodiment 3

[0125] Example 3 Differential expression of DUXAP8 gene in hepatocellular carcinoma cell lines

[0126] 1. Cell culture

[0127] Human hepatocellular carcinoma cell lines HepG2, Huh7 and normal liver cell line HL-7702 were incubated in DMEM containing 10% fetal bovine serum and 1% P / S at 37°C and 5% CO 2 , Cultivated in an incubator with a relative humidity of 90%. Change the medium once every 2-3 days, and use 0.25% EDTA-containing trypsin for routine digestion and passage.

[0128] 2. Extraction of RNA

[0129] Total cellular RNA was extracted using QIAGEN's cellular RNA extraction kit, and the specific operation was referred to the instructions.

[0130] 3. The specific steps of reverse transcription are the same as in Example 2

[0131] 4. The specific steps of QPCR amplification inspection are the same as in Example 2

[0132] 5. Results

[0133] The result is as figure 2 As shown, compared with normal liver cell lines, the expression of DUXAP8 gene was up-regulat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of DUXAP8 in hepatocellular carcinoma diagnosis and treatment. The invention discovers that expression of DUXAP8 in hepatocellular carcinoma patients is up for thefirst time, and large samples prove that DUXAP8 can be used as a detection target for auxiliary diagnosis of hepatocellular carcinoma. The invention also finds that DUXAP8 has a relation with proliferation, migration and invasion of the liver cancer cells, and prompts that DUXAP8 can be used as a medicine target for treatment of hepatocellular carcinoma and invasion and transfer of hepatocellularcarcinoma.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to the application of DUXAP8 in the diagnosis and treatment of hepatocellular carcinoma. Background technique [0002] In recent years, hepatocellular carcinoma has become one of the most common malignant tumors in my country, and its mortality rate ranks second among malignant tumors, seriously threatening the development of my country's national economy and population health (Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global statistics. CA: a cancer journal for clinicians. 2011, 61(2):69-90). Surgical resection, liver transplantation, radiotherapy and chemotherapy, interventional therapy, and molecular targeted therapy are currently the main treatment methods for liver cancer. However, due to the insidious onset of liver cancer and no obvious symptoms, most patients have lost the chance of radical surgery and relapsed after surgery. Factors such as cancer and metastasis seriou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886A61K45/00A61P35/00A61P35/04
CPCA61K45/00A61P35/00A61P35/04C12Q1/6886C12Q2600/158C12Q2600/178
Inventor 吴东杨承刚舒慧君张改英陈丽媛
Owner BEIJING MEDINTELL BIOMED CO LTD